Feature | Intra-Aortic Balloon Pumps (IABP) | December 20, 2022

Teleflex Recalls Arrow Intra-Aortic Balloon Pumps for Short Battery

Arrow International, LLC, a Subsidiary of Teleflex, Inc, recalls Arrow AutoCAT 2, AC3 intra-aortic balloon pumps for unexpectedly short battery run times

Arrow International, LLC, a Subsidiary of Teleflex, Inc, recalls Arrow AutoCAT 2, AC3 intra-aortic balloon pumps for unexpectedly short battery run times

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic Balloon PumpsArrow International, LLC, a subsidiary of Teleflex, Inc, is recalling the pumps after receiving complaints that battery power is not lasting as long as expected. A fully charged battery should last 90 minutes, however, multiple users report the devices are experiencing shorter run times. When the device is experiencing a short battery run time, the battery life warnings, designed to sound at 20, 10, and 5 minutes of battery power remaining, are also inaccurate as the battery depletes more rapidly than indicated. If the pump’s battery depletes, the pump may stop when operating on battery power only.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death.

Recalled Product 

  • Product Names: Arrow AutoCAT 2, AutoCAT 2 Refurbished, AeroautoCAT 2, AutoCAT 2 Wave, AutoCAT 2 Wave refurbished, AeroautoCAT 2 Wave, AeroautoCAT 2 Wave refurbished, AC3 NA/EMEA, AC3 Optimus NA/EMEA, AC3 Optimus NA/ EMEA, AC3 Optimus Refurbished, AC3 Optimus NA/ AJLA 
  • Product Models and Codes: See Recall Database entries
  • Distribution Dates: July 1, 2022 to September 30, 2022
  • Devices Recalled in the U.S.: 2,132
  • Date Initiated by Firm: October 17, 2022

Device Use

The Arrow Intra-Aortic Balloon Pumps (IABP) are cardiac (heart) assist devices used with patients undergoing cardiac and non-cardiac surgery, and to treat adult patients who have acute coronary syndrome or complications of heart failure.

Reason for Recall

Arrow International, LLC, a subsidiary of Teleflex, Inc, is recalling Arrow AutoCAT 2 and AC3 Intra-Aortic Balloon Pumps after receiving complaints that battery power is not lasting as long as expected. A fully charged battery should last 90 minutes, however, multiple users report the devices are experiencing shorter run times. The battery life warnings, designed to sound at 20, 10, and 5 minutes of battery power remaining, are also inaccurate as the battery depletes more rapidly than indicated. 
If the pump’s battery depletes, the pump may stop when operated on battery power only. Sudden stopping of the pump’s mechanical support to the patient’s heart can lead to cardiac arrest, stroke, or death. 
There have been 241 complaints, with 135 reported pump stops. No deaths have been reported related to this issue. 

Who May be Affected 

  • Health care personnel providing care using the Arrow AutoCAT 2 or AC3 Intra-Aortic Balloon Pumps.
  • People who receive care using Arrow AutoCAT 2 or AC3 Intra-Aortic Balloon Pumps, especially those who will use the devices on battery power at some point in their care. 

What to Do 

On October 17, 2022, Teleflex sent customers an Urgent Medical Device Notification letter. The letter recommended the following actions for users: 
Immediate actions if the intra-aortic balloon pump battery fails: 

  • Immediately connect to an AC power source to continue therapy.
  • Transfer the patient to an alternative intra-aortic balloon pump if AC power is not readily available. 
  • Keep a backup intra-aortic balloon pump fully charged and readily available.
  • If pumping cannot be restored within 15 to 30 minutes: 
    • Manually inflate and deflate the intra-aortic balloon several times per hour to reduce the risk of thrombus formation. 
    • Consider removing the balloon. 
  • Review the intra-aortic balloon pump user manual for additional instructions, cautions, and warnings related to proper battery operation and maintenance.

Actions to reduce the risk of short battery run time:

  • Keep the pump plugged into an AC outlet whenever possible during patient use to prevent
  • the battery from depleting.
  • Keep the pump plugged into an AC outlet when the system is not in use to keep the batteries at a full charge.
  • Ensure the battery is fully charged before transporting the patient. 
  • Have a backup intra-aortic balloon pump fully charged and readily available.
  • Ensure the batteries are replaced by qualified personnel  (per the operator manual) when:
    • Battery run time is less than 90 minutes
    • There is visual damage to the battery
    • The battery has been in service for 3 years. 
  • Perform a battery load test every 12 months with qualified service personnel. 
  • Quarantine any product with a battery load issue and contact Teleflex Customer Service to arrange service. 
  • Do not transport patients with affected intra-aortic balloon pump devices until a battery load test is performed, if one has not been completed in the last 12 months.

The letter also included required actions for facilities. 

  • Send a copy of this notification to all relevant personnel in the organization, including, at a minimum, personnel in the following departments: 
    • Coronary Care
    • Interventional Cardiology
    • Cardiac Catheter Lab
    • Anesthesiology
    • Intensive Care (Adult, Pediatric, Neonatal)
    • Critical Care
    • Emergency Department
    • Vascular Access Service
    • Operating Room/Service
    • Surgery
    • Resident Training
    • Biomedical Engineering
  • Immediately check inventory of Arrow AutoCAT 2 and Arrow AC3 Intra-Aortic Balloon Pumps, whether stored or in use.
  • Mark the applicable checkbox on the company’s Acknowledgement Form whether you do or do not have affected product, then return the form to Teleflex Customer Service.
  • Place a copy of this corrective notice with all affected products.

Contact Information 

Customers with questions about this recall should call Teleflex customer service at 866-396-2111 or email [email protected]

For more information: https://www.fda.gov/medical-devices/medical-device-recalls


Related Content

News | Heart Failure

February 22, 2024 — Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding ...

Home February 22, 2024
Home
News | Heart Failure

February 15, 2024 — Canary Medical, a medical data company focused on the development and commercialization of its ...

Home February 15, 2024
Home
News | Heart Failure

February 12, 2023 — A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully ...

Home February 12, 2024
Home
News | Heart Failure

January 30, 2024 — Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single ...

Home January 30, 2024
Home
News | Heart Failure

January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home January 23, 2024
Home
News | Heart Failure

January 16, 2024 — Cardiac Dimensions, a leader in the development of innovative and minimally invasive treatment ...

Home January 16, 2024
Home
News | Heart Failure

November 30, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 30, 2023
Home
News | Heart Failure

November 30, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home November 30, 2023
Home
News | Heart Failure

November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells ...

Home November 16, 2023
Home
News | Heart Failure

November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a person ...

Home November 16, 2023
Home
Subscribe Now